Skip to main navigation
  • Home
  • Engineered with Purpose
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds
explore the
possibilities

Synlogic Therapeutics

Investor Relations

IR menu

  • Overview
  • News
    News Releases In the News
  • Events & Presentations
    Events Presentations
  • Publications
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Corporate Governance
    Governance Highlights Leadership Board of Directors Committee Composition Board Diversity Matrix
  • Financials
    SEC Filings Quarterly Results
  • Investor Resources
    FAQs Contact IR Email Alerts RSS Feeds

SEC Filing Details

  • Home
  • Engineered with Purpose
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds

SEC Filing Details

Document Details

Form
4
Filing Date
May 25, 2022
Document Date
May 24, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Synlogic
Issuer
SYNLOGIC, INC.
Filer
JENSEN MICHAEL VANGSTED

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Investor Resources

  • Contact IR
  • Investor FAQs
  • RSS Feeds

Investor Email Alerts

Synlogic Therapeutics

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

  • Twitter
  • LinkedIn
  • Youtube
  • Facebook
  • Instagram

Privacy and Terms

© 2023 Synlogic
Privacy Policy